Headline : Pfizer%26#039;s Covid drug Paxlovid may reduce the risk of developing long Covid, study says

Read more from the original article on here at www.cnbc.com.

---

No. of Paragraph 19

People who take Pfizer's Covid antiviral treatment Paxlovid shortly after infection may reduce their risk of developing long Covid, regardless of their age, vaccination status or infection history, new research suggests.

The study, published in the journal JAMA Internal Medicine on Thursday, found that people who took Paxlovid within five days of a positive Covid test saw a 26% lower risk of long Covid compared with those who didn't receive it. More than 35,000 people took the oral Covid pill in the study, while 246,000 did not. 

The study only enrolled people who are eligible for Paxlovid under emergency use authorization. That includes adults over 50, or those who have an underlying medical condition such as high blood pressure or diabetes.

The findings suggest the benefits of Paxlovid may go beyond what the drug is designed for, which is to treat adults and children who are at a higher risk of ending up in the hospital or dying from a Covid infection. The drug still demonstrated that intended benefit in the study, lowering the risk of death by 47% and hospitalization by 24% about a month after initial infection.

Read more from the original article on here at www.cnbc.com.

Related Headlines : Pfizer%26#039;s Covid drug Paxlovid may reduce the risk of developing long Covid, study says (in Google.com):

Hello, below you have a "Web" tab to read more content and an "Image" tab to get related pictures

Example : Trends, Country, News, Jobs, Scholarships, Investment, Business, Politics, Adverts, Fashion, Events, Technology and more.